NCT04776499View on ClinicalTrials.gov

Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Drug Drug InteractionSafety Issues
Interventions
DRUG

Propylthiouracil, Riociguat, Perphenazine

"Administration of propylthiouracil, riociguat, and perphenazine in combination~Investigational medicinal product (IMP):~Propylthiouracil: 100 mg, Riociguat: 1 mg, Perphenazine: 16 mg"

Trial Locations (1)

69120

UniversitätsKlinikum Heidelberg - Medizinische Klinik, Heidelberg

All Listed Sponsors
collaborator

European Commission

OTHER

lead

Maastricht University

OTHER

NCT04776499 - Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers | Biotech Hunter | Biotech Hunter